FDA Orders New Eye-Risk Warnings on Ozempic, Wegovy and Other Popular Weight-Loss Drugs
Manufacturers of blockbuster weight-loss medications such as Ozempic and Zepbound will be required to add warnings about a rare eye condition that can cause permanent vision loss, the U.S. Food and Drug